BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38679399)

  • 1. Transcriptomic analysis reveals the critical role of chemokine signaling in the anti-atherosclerosis effect of Xuefu Zhuyu decoction.
    Jia D; Zhao M; Zhang X; Cheng X; Wei Q; Lou L; Zhao Y; Jin Q; Chen M; Zhang D
    J Ethnopharmacol; 2024 Oct; 332():118245. PubMed ID: 38679399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of Xuefu Zhuyu decoction on serum asymmetric dimethylarginine in atherosclerosis rabbits].
    Li Y; Zhao A; Zeng H; Lin G; Jiang H
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1530-4. PubMed ID: 19777840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buyang Huanwu Decoction ameliorates atherosclerosis by regulating TGF-β/Smad2 pathway to promote the differentiation of regulatory T cells.
    Chen S; Wang Y; Liang C; Li J; Li Y; Wu Q; Liu Z; Pang X; Chang YX
    J Ethnopharmacol; 2021 Apr; 269():113724. PubMed ID: 33359003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of Xuefu Zhuyu Decoction in treatment of myocardial infarction based on network pharmacology and molecular docking].
    Lin JG; Yao KW; Wang QQ; Hua X
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):885-893. PubMed ID: 33645093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and mechanism of Xuefu Zhuyu Decoction on model rats of coronary heart disease with heart blood stasis syndrome based on metabolomics].
    Li J; Guo ZH; Liu JH; Zhong SJ; Kuang HF; Yang Y; Liu Y; Zhang QY
    Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(20):5623-5631. PubMed ID: 38114155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Si-Miao-Yong-An decoction on the differentiation of monocytes, macrophages, and regulatory T cells in ApoE
    Chen XN; Ge QH; Zhao YX; Guo XC; Zhang JP
    J Ethnopharmacol; 2021 Aug; 276():114178. PubMed ID: 33945857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Zhuyu Pills promote polarization of macrophages toward M2 phenotype to prevent atherosclerosis via PPARγ/NF-κB signaling pathway].
    Song W; Zhang ZY; Wang K; Qiu HR; Zhang XB; Shen T
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):243-250. PubMed ID: 38403357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZeXieYin formula alleviates atherosclerosis by inhibiting the MAPK/NF-κB signaling pathway in APOE-/- mice to attenuate vascular inflammation and increase plaque stability.
    Huang R; Sun Y; Liu R; Zhu B; Zhang H; Wu H
    J Ethnopharmacol; 2024 Jun; 327():117969. PubMed ID: 38437888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Xuefu Zhuyu Decoction in the treatment of coronary heart disease based on integrated metabolomics and network pharmacology approach.
    Yang Y; Su C; Zhang XZ; Li J; Huang SC; Kuang HF; Zhang QY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1223():123712. PubMed ID: 37060624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanmaitong Granule Attenuates Atherosclerosis by Inhibiting Inflammatory Immune Response in ApoE
    Yang M; Jiao H; Li Y; Zhang L; Zhang J; Zhong X; Xue Y
    Drug Des Devel Ther; 2022; 16():3145-3168. PubMed ID: 36148321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMT-based proteomics analysis reveals the protective effects of Xuefu Zhuyu decoction in a rat model of traumatic brain injury.
    Zhou D; Liu J; Hang Y; Li T; Li P; Guo S; Liu T; Xia Z; Wang Y
    J Ethnopharmacol; 2020 Aug; 258():112826. PubMed ID: 32298754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Banxia Baizhu Tianma Decoction in alleviating atherosclerosis based on the regulation of perivascular adipose.
    Chen J; Wang L; Wang Y; Jin A; Wang S; Li X; Jiang YH
    J Ethnopharmacol; 2024 Mar; 322():117575. PubMed ID: 38103846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QiShenYiQi pill inhibits atherosclerosis by promoting reverse cholesterol transport PPARγ-LXRα/β-ABCA1 pathway.
    Xie J; Peng L; Wang T; Yang C; Chen N; Feng X; Wu T; Xu T; Chen Y
    J Ethnopharmacol; 2023 Oct; 315():116684. PubMed ID: 37230281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network pharmacological analysis of Xuefu Zhuyu decoction in the treatment of atherosclerosis.
    Yuan J; Yan F; Li W; Yuan G
    Front Pharmacol; 2022; 13():1069704. PubMed ID: 36532728
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
    Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
    Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hawthorn leaf flavonoids alleviate the deterioration of atherosclerosis by inhibiting SCAP-SREBP2-LDLR pathway through sPLA2-ⅡA signaling in macrophages in mice.
    Bai X; Wang S; Shu L; Cao Q; Hu H; Zhu Y; Chen C
    J Ethnopharmacol; 2024 Jun; 327():118006. PubMed ID: 38442806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xuefu Zhuyu decoction promotes synaptic plasticity by targeting miR-191a-5p/BDNF-TrkB axis in severe traumatic brain injury.
    Pei Z; Guo X; Zheng F; Yang Z; Li T; Yu Z; Li X; Guo X; Chen Q; Fu C; Tang T; Feng D; Wang Y
    Phytomedicine; 2024 Jul; 129():155566. PubMed ID: 38565001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE
    Cheng XL; Ding F; Wang DP; Zhou L; Cao JM
    Peptides; 2019 Nov; 121():170122. PubMed ID: 31386895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipingshu capsule improves atherosclerosis associated with lipid regulation and inflammation inhibition in apolipoprotein E-deficient mice.
    Xu J; Ma C; Chen M; Rong S; Gao H; Xia Z; Huang F
    Lipids Health Dis; 2018 Jul; 17(1):182. PubMed ID: 30064511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xinmaikang (XMK) tablets alleviate atherosclerosis by regulating the SREBP2-mediated NLRP3/ASC/Caspase-1 signaling pathway.
    Hou C; Jiang X; Sheng W; Zhang Y; Lin Q; Hong S; Zhao J; Wang T; Ye X
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117240. PubMed ID: 37777030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.